Showing 101,061 - 101,080 results of 111,326 for search '(( 12 m decrease ) OR ( 5 ((((nn decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.68s Refine Results
  1. 101061

    DataSheet_3_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.pdf by Jianfeng Shu (12518655)

    Published 2023
    “…Background<p>Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. …”
  2. 101062

    Table_1_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.xlsx by Jianfeng Shu (12518655)

    Published 2023
    “…Background<p>Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. …”
  3. 101063

    Image_1_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.tif by Qingling Han (11477659)

    Published 2021
    “…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”
  4. 101064

    DataSheet_1_MicroLet-7b Regulates Neutrophil Function and Dampens Neutrophilic Inflammation by Suppressing the Canonical TLR4/NF-κB Pathway.pdf by Binzhen Chen (10489685)

    Published 2021
    “…Survival (n=10), changes in liver and lungs histopathology (n=4), circulating neutrophil counts (n=4), the liver-body weight ratio (n=4–7), and the lung wet-to-dry ratio (n=5–6) were recorded. We found that overexpression of miR-let-7b could significantly down-regulate the expression of human-derived neutrophilic TLR4 at a post-transcriptional level, a decreased level of proinflammatory factors including interleukin-6 (IL-6), IL-8, tumor necrosis factor α (TNF-α), and an upregulation of anti-inflammatory factor IL-10 in vitro. …”
  5. 101065

    The Effectiveness of Financial Incentives for Health Behaviour Change: Systematic Review and Meta-Analysis by Emma L. Giles (533647)

    Published 2014
    “…ID=CRD42012002393#.Uv7D-7RFA7A" target="_blank">CRD42012002393</a></p></div>…”
  6. 101066

    iES group analysis: Mapping induced gamma oscillations during visual stimulation. by Peter W. Donhauser (4824822)

    Published 2018
    “…<p><i>a) Subspace computation, example subject:</i> (left) values of the quality function <i>f</i><sub><i>induced</i></sub> for all the spatial patterns in the MEG data, ranked in decreasing order. …”
  7. 101067

    Image_9_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.TIF by Yinjiang Zhang (5030006)

    Published 2021
    “…Furthermore, the expression of CLEC4H1 (ASGR1) and CLEC4H2 (ASGR2) exhibited a significant relation to clinical stages. However, the expression of CLEC4A, CLEC4D, CLEC4E, CLEC4J (FCER2), CLEC4K (CD207), CLEC4G, CLEC4H1, CLEC4M, and CLEC4H2 decreased with tumor progression. …”
  8. 101068

    The Hepatoselective Glucokinase Activator PF-04991532 Ameliorates Hyperglycemia without Causing Hepatic Steatosis in Diabetic Rats by Derek M. Erion (568011)

    Published 2014
    “…During a hyperglycemic clamp in Goto-Kakizaki rats, the glucose infusion rate was increased approximately 5-fold with PF-04991532. …”
  9. 101069

    Data_Sheet_1_The pattern from the first three rounds of vaccination: declining vaccination rates.docx by Jian Wu (41301)

    Published 2023
    “…</p>Results<p>A total of 957 participants with chronic disease and 5,454 participants without chronic disease were included in this survey. …”
  10. 101070

    Image_4_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.tif by Qingling Han (11477659)

    Published 2021
    “…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”
  11. 101071

    Table_1_3D-Printed PCL/PPy Conductive Scaffolds as Three-Dimensional Porous Nerve Guide Conduits (NGCs) for Peripheral Nerve Injury Repair.DOCX by Sanjairaj Vijayavenkataraman (7505000)

    Published 2019
    “…PCL/PPy scaffolds with three different concentrations of PPy-b-PCL (0.5, 1, and 2% v/v) were fabricated as a mesh (pore size 125 ± 15 μm) and the effect of incorporation of PPy-b-PCL on mechanical properties, biodegradability, and conductivity of the NGCs were studied. …”
  12. 101072

    Table_6_Impact of Computed Tomography-Based, Artificial Intelligence-Driven Volumetric Sarcopenia on Survival Outcomes in Early Cervical Cancer.docx by Qingling Han (11477659)

    Published 2021
    “…During primary treatment, significant decreases in waist skeletal muscle (median, −3.9%; p < 0.001) and total fat (median, −5.3%; p < 0.001) were observed. …”
  13. 101073

    Image_7_CLEC4s as Potential Therapeutic Targets in Hepatocellular Carcinoma Microenvironment.TIF by Yinjiang Zhang (5030006)

    Published 2021
    “…Furthermore, the expression of CLEC4H1 (ASGR1) and CLEC4H2 (ASGR2) exhibited a significant relation to clinical stages. However, the expression of CLEC4A, CLEC4D, CLEC4E, CLEC4J (FCER2), CLEC4K (CD207), CLEC4G, CLEC4H1, CLEC4M, and CLEC4H2 decreased with tumor progression. …”
  14. 101074

    Table_1_Current status, trends, and predictions in the burden of silicosis in 204 countries and territories from 1990 to 2019.DOCX by Xinglin Yi (16447332)

    Published 2023
    “…The age-period-cohort analysis forecasted a decreasing trend of the burden of silicosis from 2019 to 2044.…”
  15. 101075

    Table_3_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.xlsx by Jianfeng Shu (12518655)

    Published 2023
    “…Background<p>Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. …”
  16. 101076

    DataSheet_1_Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.pdf by Jianfeng Shu (12518655)

    Published 2023
    “…Background<p>Lung adenocarcinoma (LUAD) as a frequent type of lung cancer has a 5-year overall survival rate of lower than 20% among patients with advanced lung cancer. …”
  17. 101077

    Image 2_MIF tautomerase inhibitor TE-11 prevents inflammatory macrophage activation and glycolytic reprogramming while reducing leukocyte migration and improving Crohn’s disease-li... by Eszter Vámos (11081587)

    Published 2025
    “…Here, we tested TE-11, a potent MIF tautomerase inhibitor (IC<sub>50</sub> = 5.63 μmol/dm<sup>3</sup>) in experimental Crohn’s disease in male mice, in leukocyte recruitment and in inflammatory M1 macrophage activation.…”
  18. 101078

    Encountering epidemic effects of leaf spot disease (<i>Alternaria brassicae</i>) on <i>Aloe vera</i> by fungal biocontrol agents in agrifields—An ecofriendly approach by Swapan Kumar Ghosh (5007290)

    Published 2018
    “…<i>harzianum</i>, standardized at a rate of 2.5 L / plot (36 sq ft) (10<sup>8</sup> spores/ mL) are suggested for the ecofriendly management of this epidemic leaf spot disease of <i>Aloe vera</i> in agricultural fields.…”
  19. 101079

    Validation of the optimum formula. by Randa Mohammed Zaki (21637175)

    Published 2025
    “…The optimized formulation was found to be composed of 19.999, 111.869 and 15 mgs of cholesterol, span 60, and SDC, respectively with a desirability of 0.753. EE%, VS, and ZP were predicted to be 88.4977%, 594.592 nm, and −44.2354 mV, respectively. …”
  20. 101080

    Image 1_MIF tautomerase inhibitor TE-11 prevents inflammatory macrophage activation and glycolytic reprogramming while reducing leukocyte migration and improving Crohn’s disease-li... by Eszter Vámos (11081587)

    Published 2025
    “…Here, we tested TE-11, a potent MIF tautomerase inhibitor (IC<sub>50</sub> = 5.63 μmol/dm<sup>3</sup>) in experimental Crohn’s disease in male mice, in leukocyte recruitment and in inflammatory M1 macrophage activation.…”